الخميس 10 محرم 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Participants with Sickle Cell Disease and an Open-Label Pharmacokinetics Study in Pediatric Participants with Sickle Cell Disease | Global Therapeutics Inc | Ongoing | Osivelotor | 2/3 | C5351004 (GBT021601) | Prince Mohammad Bin Naser Hospital (Jazan), King Abdulaziz Medical City NG (Riyadh) |
| Effect and safety of Semaglutide in diabetic kidney transplant recipients with obesity | AbbVie | Ongoing | Risankizumab | 3 | M23-784 | King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam) |
| INTERnational STudy Evaluating Lupus Outcomes after Anifrolumab Real-World Use (INTERSTELLAR): Multi-National, Observational, Prospective, Post-Launch, Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice | Astrazeneca | Ongoing | Anifrolumab | 4 | TMP-0010230 | Aseer Central Hospital (Abha), International Medical Center (Jeddah), King Khalid University Hospital (Riyadh) |
| Effect and safety of Semaglutide in diabetic kidney transplant recipients with obesity | King Faisal Specialist Hospital and Research Center (Riyadh) | Ongoing | Semaglutide | 3 | 2241130 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Survey assessing prospective patient’s short-term treatment satisfaction and Quality of Life in patients with Hidradenitis Suppurativa initiated on Cosentyx (Secukinumab) in routine clinical practice in Saudi Arabia | Novartis | Ongoing | Secukinumab | 4 | CAIN457MSA | King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| Comparing the effectiveness of buccal infiltration of different volumes of Articaine for extraction of mandibular posterior teeth- A randomized clinical trial. | Dental Clinic-collage of Dentistry-Qassim Unviersity | Ongoing | ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE | 4 | 6074514624 | Dental Clinic-collage of Dentistry-Qassim Unviersity (Al-Qassim) |
| A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod IV in Adult Participants With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis | Argenx BV | Ongoing | Efgartigimod IV | 3 | ARGX-113-2308 | King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh) |
| A Phase 4, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Effectiveness and Safety of Tirzepatide Once Weekly in Adult Participants with Type 2 Diabetes during Ramadan (T-RAM) | Boehringer Ingelheim | Ongoing | BI 690517 Empagliflozin | 4 | 1378-0020 | King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz University Hospital (Jeddah) |
| INTERnational STudy Evaluating Lupus Outcomes after Anifrolumab Real-World Use (INTERSTELLAR): Multi-National, Observational, Prospective, Post-Launch, Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice | AstraZeneca | Ongoing | Anifrolumab | 4 | TMP-0010230 | Aseer Central Hospital (Abha), International Medical Center (Jeddah) |
| Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects with Severe or Moderately Severe Hemophilia B with Detectable Pretreatment AAV5 Neutralizing Antibodies | CSL Behring LLC | Ongoing | HEMGENIX (etranacogene dezaparvovec) | 3b | CSL222_3005 | King Faisal Specialist Hospital and Research Center (Riyadh) |
تاريخ آخر تحديث: 08/05/2025 بتمام الساعة 03:17 مساء بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.